1. Home
  2. KRO vs ARQT Comparison

KRO vs ARQT Comparison

Compare KRO & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$4.63

Market Cap

503.9M

Sector

Industrials

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$28.27

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRO
ARQT
Founded
1916
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.9M
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KRO
ARQT
Price
$4.63
$28.27
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
2
7
Target Price
$6.00
$24.83
AVG Volume (30 Days)
396.9K
2.0M
Earning Date
11-06-2025
10-28-2025
Dividend Yield
4.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,864,200,000.00
$317,929,000.00
Revenue This Year
N/A
$85.51
Revenue Next Year
$6.29
$30.74
P/E Ratio
N/A
N/A
Revenue Growth
0.01
129.21
52 Week Low
$4.08
$11.13
52 Week High
$10.12
$31.77

Technical Indicators

Market Signals
Indicator
KRO
ARQT
Relative Strength Index (RSI) 45.21 51.12
Support Level $4.62 $27.55
Resistance Level $4.84 $28.90
Average True Range (ATR) 0.24 1.15
MACD -0.01 -0.55
Stochastic Oscillator 16.02 18.58

Price Performance

Historical Comparison
KRO
ARQT

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: